Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
| Status: | Enrolling by invitation |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 1/25/2019 |
| Start Date: | March 22, 2017 |
| End Date: | April 1, 2020 |
Medical Provider Experience and Assessment on Documenting Prescribing and Plan of Care Changes Due to Pharmacogenomics Testing
Current providers' standard operating procedures on pharmacogenomic testing patients
The general design of this study is collecting data and reviewing Principal Investigators'
Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific
SOP.
Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific
SOP.
Inclusion Criteria:
- Must be a Medical Practitioner
- Medical Doctor (MD)
- Doctor of Osteopathic (DO)
- Physician Assistant (PA)
- Advanced Practice Registered Nurse (APRN)
- Nurse Practioner (NP)
- Must have a current standard operating procedure that includes obtaining/reviewing
medical history.
Exclusion Criteria:
- Government-funded insurance data cannot be included in the study.
We found this trial at
1
site
Click here to add this to my saved trials
